Clinical Trials Logo

Filter by:
NCT ID: NCT04640935 Completed - Clinical trials for Non Small Cell Lung Cancer

Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.

AVATAX
Start date: October 1, 2019
Phase:
Study type: Observational

The aim of the study is to evaluate the paclitaxel-bevacizumab combination retrospectively and multicenter in current practice, with subgroup analyses of the following patients: patients who have previously received immunotherapy, patients with an EGFR or ALK oncogenic addiction pathway, patients who have previously received taxanes or anti-angiogenic agents.

NCT ID: NCT04640376 Completed - Acute Pain Clinical Trials

Paracetamol UNIFLASH for Buccal Use Phase III Trial in Acute Pain Due to a Tooth Extraction

Start date: March 24, 2021
Phase: Phase 3
Study type: Interventional

This study aims to evaluate the analgesic efficacy of single dose of a new paracetamol formulation (paracetamol UNIFLASH) for buccal use in comparison to two different doses of an oral paracetamol form controlled versus placebo.

NCT ID: NCT04640194 Completed - Clinical trials for Acute Respiratory Distress Syndrome

A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19

TRISTARDS
Start date: December 16, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

This is a study in adults with severe breathing problems because of COVID-19. People who are in hospital on breathing support can participate in the study. The purpose of the study is to find out whether a medicine called alteplase helps people get better faster. The study has 2 parts. In the first part, participants are put into 3 groups by chance. Participants in 2 of the groups get 2 different doses of alteplase, in addition to standard treatment. Participants in the third group get standard treatment. In the second part of the study, participants are put into 2 groups by chance. One group gets alteplase and standard treatment. The other group gets only standard treatment. Alteplase is given as an infusion into a vein. In both study parts, treatments are given for 5 days. Doctors monitor patients and check whether their breathing problems improve. They compare results between the groups after 1 month. Participants are in the study for 3 months.

NCT ID: NCT04639609 Completed - Breast Cancer Clinical Trials

Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04)

PROTECT-04
Start date: September 29, 2020
Phase: N/A
Study type: Interventional

This is a transversal monocentric study comparing two groups of women (group 1, patient group : patients who have been treated for a breast cancer with taxane-based chemotherapy ; group 2, control group : healthy volunteers). The aim of this study is to evaluate if a difference exists regarding the maximal isometric muscle strength between group 1 and 2.

NCT ID: NCT04639037 Completed - Hypotension Clinical Trials

Control Mean Arterial Pressure in the Intensive Care Unit

COMAP-ICU
Start date: January 8, 2021
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to compare two different strategies of postoperative mean arterial pressure (MAP) management (manual versus automated) in patients who underwent a major surgery and admitted in the intensive care unit or post-anesthesia care unit for postoperative care. The investigators hypothesis is that the automated group will spend more time in a predetermined target MAP range of 80-90 mmHg compared to the manual group.

NCT ID: NCT04638712 Completed - Breast Cancer Clinical Trials

Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients

PROTECT-03
Start date: September 16, 2020
Phase: N/A
Study type: Interventional

This is an interventional, prospective and monocentric study. This study includes the evaluation before and after (neo)adjuvant therapy of : - one group of patients receiving anthracyclines and taxanes - a second group of patients receiving anthracyclines, taxanes and trastuzumab.

NCT ID: NCT04638361 Completed - Clinical trials for Surgery--Complications

Laryngeal Disorders After Childhood Cardiac Surgery

RECUP-TML
Start date: August 26, 2021
Phase:
Study type: Observational

Laryngeal disorders after childhood cardiac surgery is a complication well described in the literature. However, the long term progression of the affected children has never been studied (all the studies stopped before 2 years of follow up).

NCT ID: NCT04637867 Completed - Infection Viral Clinical Trials

COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)

Start date: November 23, 2020
Phase: N/A
Study type: Interventional

There are still uncertainties about the existence of protective immunity and the duration of protective antibodies in patients infected with SARS-CoV-2. Serological testing is an appropriate tool for epidemiological investigations to assess the persistence of antibodies over time. The nature of the immune response induced by this virus is also poorly understood. This ancillary study aims at assessing the immunological characteristics of patients that participated in the NOSO-COR study at Hospices Civils de Lyon six and twelve months after the initial infectious episode. Two visits will be scheduled at 6 and 12 months (± 1 month) after the initial SARS-CoV-2 infectious episode, Blood, saliva and nasopharyngeal samples will be collected for seroprevalence and immunological investigation.

NCT ID: NCT04637672 Completed - Clinical trials for Inflammatory Myositis

Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)

MASC
Start date: December 19, 2013
Phase:
Study type: Observational [Patient Registry]

Myositis are rare diseases for which the development of a cohort associated with a bank of biological samples (biobank) will allow for the conduct of researches to better delineate the underlying pathophysiology and find cures. This prospective cohort of patients with myositis will allow for identification of factors favouring the occurrence of myositis, whether they are constitutional (genetic) or acquired (environmental or drug). Different subgroups of myositis used for prognostication will be identified based on clinico-demographical variables, the nature of the organs involved beyond peripheral muscles (cardiac, diaphragm) and biomarkers abnormalities.

NCT ID: NCT04637126 Completed - Sinus Rhythm Clinical Trials

Cardiac Output Monitoring by Transpulmonary Thermodilution and Transthoracic Echocardiography in Critically Ill Patients

TPTD-TTE-SR
Start date: March 6, 2020
Phase:
Study type: Observational

Cardiac output monitoring is a key component for the diagnosis and management of critically ill patients. The two less invasive methods commonly used in intensive care are transthoracic echocardiography and transpulmonary thermodilution. The objective of this study is to compare accuracy and trending ability of CO measurement by TPTD and TTE in critically ill patients with sinus rhythm.